Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Beyond traditional roles: vitamin D and erythropoietin as immune modulators in kidney diseases
Source: Article title. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Review / evidence synthesis.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Publisher article type: review-article
Source: Publisher publication metadata.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Beyond traditional roles: vitamin D and erythropoietin as immune modulators in kidney diseases
Review / evidence synthesis · Clinical Kidney Journal · 2026
Original publication title
Beyond traditional roles: vitamin D and erythropoietin as immune modulators in kidney diseases
© The Author(s) 2026. Published by Oxford University Press on behalf of the ERA.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
ABSTRACT
Vitamin D and erythropoietin (EPO) are kidney-derived hormones classically known for their roles in mineral metabolism and erythropoiesis, respectively. Beyond these functions, growing evidence indicates that both molecules exert broad immunomodulatory effects on innate and adaptive immunity. Vitamin D signalling through the vitamin D receptor shapes dendritic cell maturation, promotes regulatory T-cell induction, and suppresses pro-inflammatory T helper cell responses. Similarly, EPO acts as a pleiotropic cytokine capable of modulating macrophage activation, T-cell proliferation, and inflammatory signalling pathways through EPO receptor-dependent mechanisms.
In chronic kidney disease (CKD), reduced renal synthesis of active vitamin D and impaired endogenous EPO production frequently coexist, contributing not only to disturbances in mineral metabolism and anaemia, but possibly also to immune dysregulation. Besides CKD, immune dysregulation is common across diverse nephrological conditions, including immune-mediated nephropathies and transplantation, where inflammatory and alloimmune responses critically influence disease progression and graft outcomes. Increasing experimental and clinical evidence suggests that vitamin D and EPO may modulate these processes and represent potential therapeutic targets.
This narrative review summarizes current knowledge on the immunomodulatory properties of vitamin D and EPO, their mechanisms of action on immune cells, and their relevance in kidney disease and transplantation.
Authors’ abstract
ABSTRACT
Vitamin D and erythropoietin (EPO) are kidney-derived hormones classically known for their roles in mineral metabolism and erythropoiesis, respectively. Beyond these functions, growing evidence indicates that both molecules exert broad immunomodulatory effects on innate and adaptive immunity. Vitamin D signalling through the vitamin D receptor shapes dendritic cell maturation, promotes regulatory T-cell induction, and suppresses pro-inflammatory T helper cell responses. Similarly, EPO acts as a pleiotropic cytokine capable of modulating macrophage activation, T-cell proliferation, and inflammatory signalling pathways through EPO receptor-dependent mechanisms.
In chronic kidney disease (CKD), reduced renal synthesis of active vitamin D and impaired endogenous EPO production frequently coexist, contributing not only to disturbances in mineral metabolism and anaemia, but possibly also to immune dysregulation. Besides CKD, immune dysregulation is common across diverse nephrological conditions, including immune-mediated nephropathies and transplantation, where inflammatory and alloimmune responses critically influence disease progression and graft outcomes. Increasing experimental and clinical evidence suggests that vitamin D and EPO may modulate these processes and represent potential therapeutic targets.
This narrative review summarizes current knowledge on the immunomodulatory properties of vitamin D and EPO, their mechanisms of action on immune cells, and their relevance in kidney disease and transplantation.
Publication and source details
Original title: Beyond traditional roles: vitamin D and erythropoietin as immune modulators in kidney diseases
Lorenza Magagnoli; Sofia Bin; Paolo Cravedi; Mario Cozzolino
Clinical Kidney Journal · 2026
Correspondence to: Mario Cozzolino; E-mail: mario.cozzolino@unimi.it© The Author(s) 2026. Published by Oxford University Press on behalf of the ERA.2026https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T10:42:19.302114+00:00
DOI: 10.1093/ckj/sfag120 · PMC13156944